Cargando…
Identification of APC Mutation as a Potential Predictor for Immunotherapy in Colorectal Cancer
To date, anticancer immunotherapy has presented some clinical benefits to most of advanced mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H) colorectal cancer (CRC) patients. In addition to MSI status, we aimed to reveal the potential predictive value of adenomatous polyposis...
Autores principales: | Feng, Fen, Sun, Huake, Zhao, Zhikun, Sun, Chao, Zhao, Yongtian, Lin, Hanqing, Yang, Jie, Xiao, Yajie, Wang, Wei, Wu, Dongfang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300385/ https://www.ncbi.nlm.nih.gov/pubmed/35874638 http://dx.doi.org/10.1155/2022/6567998 |
Ejemplares similares
-
Good Tumor Response to Chemoradioimmunotherapy in dMMR/MSI-H Advanced Colorectal Cancer: A Case Series
por: Zhou, Chengjing, et al.
Publicado: (2021) -
Durable Response to Immunotherapy With Antiangiogenic Drug in Large-Cell Lung Carcinoma With Multiple Fulminant Postoperative Metastases: A Case Report
por: Luo, Zhilin, et al.
Publicado: (2021) -
Treatment beyond progression with chemo-immunotherapy in an advanced esophageal squamous cell carcinoma patient: a case report
por: Peng, Ping, et al.
Publicado: (2021) -
Genomic correlates of programmed cell death ligand 1 (PD-L1) expression in Chinese lung adenocarcinoma patients
por: Li, Kang, et al.
Publicado: (2022) -
Specific Mutations in APC, with Prognostic Implications in Metastatic Colorectal Cancer
por: Peng, Huan, et al.
Publicado: (2023)